Dupixent (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
Approval in moderate-to-severe patients was based on pivotal trial results showing over…
Idorsia announces the nomination of three candidates for election to the Board of Directors
Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial…
Press Release: Sanofi and Regenerons Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine…
Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers
BEIJING, March 24, 2026 /PRNewswire/ -- During the Upperside World Congress 2026, Huawei…
Keolis India selects Octave Attune EAM to operate Line 3 of the Pune Metro System
PUNE, India, March 24, 2026 /PRNewswire/ -- Octave, the potential software spin-off from…
ICP DAS-BMP Highlights Full Spectrum of Medical TPU Innovations at CMEF and Medtec Japan 2026
HSINCHU, March 24, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based…
Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year — New Study Challenges Notion the Tests are Interchangeable
Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces…
New Cognex Research Reveals Manufacturers Increasingly Expect AI Vision Systems to Deliver Both High Performance and Simplicity
Global study of 500+ manufacturers shows shifting priorities, rapid deployment, and new…
Hankook’s iON Race Supports Competitive Racing at Historic Madrid E-Prix
Formula E concluded its inaugural Madrid E-Prix at the Circuito del Jarama,…
Oracle Launches AI Customer Excellence Centre to Drive Innovation Across Australia and Oceania
Sydney-based Oracle AI Customer Excellence Centre will serve as a regional hub…
